| اسم المنتج |
ginsenoside rb1 |
| الاسم بالانجليزية |
ginsenoside rb1; Sanchinoside E1; Arasaponin E1; GRb 1; Gynosaponin C; Gypenoside III; NSC 310103; Panax saponin E; Pseudoginsenoside D; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside; beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-; 20-[(6-O-hexopyranosylhexopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-hexopyranosylhexopyranoside; (2S,3R,4S,5S,6R)-2-[1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,5-dimethyl-hex-4-enoxy]-6-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,4,5-triol |
| الصيغة الجزيئية |
C54H92O23 |
| الوزن الجزيئي الغرامي |
1109.2945 |
| InChI |
InChI=1/C54H92O23/c1-23(2)10-9-14-54(8,77-48-44(69)40(65)37(62)29(74-48)22-70-46-42(67)38(63)34(59)26(19-55)71-46)24-11-16-53(7)33(24)25(58)18-31-51(5)15-13-32(50(3,4)30(51)12-17-52(31,53)6)75-49-45(41(66)36(61)28(21-57)73-49)76-47-43(68)39(64)35(60)27(20-56)72-47/h10,24-49,55-69H,9,11-22H2,1-8H3/t24-,25+,26+,27+,28+,29+,30-,31+,32-,33-,34+,35+,36+,37+,38-,39-,40-,41-,42+,43+,44+,45+,46?,47-,48-,49-,51-,52+,53+,54?/m0/s1 |
| إستراتيجية المساعدة القطرية |
41753-43-9 |
| المفوضية الأوروبية رقم |
255-532-8 |
| بنية جزيئية |
|
| كثافة |
1.44g/cm3 |
| نقطة الغليان |
1146°C at 760 mmHg |
| معامل الإنكسار |
1.625 |
| نقطة الوميض |
646.8°C |
| ضغط البخار |
0mmHg at 25°C |
| علامات على البضائع الخطرة |
 Xi:Irritant;
|
| خطر المصطلحات |
R20/21/22:;
|
| شروط الأمن |
S26:;
S36:;
|
|
